ACC in breast tissues constitutes ~1% of all invasive breast cancers and is categorized as triple-negative for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Here, ERBB2 is linked to adrenal cortex carcinoma.